Unraveling the mysteries of drug resistance in melanoma with CRISPR-Cas9

› Forums › General Melanoma Community › Unraveling the mysteries of drug resistance in melanoma with CRISPR-Cas9

  • Post
Viewing 0 reply threads
  • Replies
      • August 24, 2018 at 5:57 pm
      ed williams
      Participant

        Hi Anon, this topic has come up before of Gene editing "Crispr-cas9" and now new "cas12a' but not close to being ready for prime time. If i understand the problems that they are facing is getting the target and not editing random genes that are health which could cause all kinds of problems. Here is another link to piercebiotech article, the one above didn't work for me!!! https://www.fiercebiotech.com/biotech/a-better-enzyme-for-crispr-gene-editing

    Viewing 0 reply threads
    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics